Sun Pharma Launches Taro-Methylphenidate ER for ADHD
Mumbai, India and Brampton, Ontario, Canada, September 21, 2026 Sun Pharmaceutical Industries Limited (Sun Pharma) has announced the commercial...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mumbai, India and Brampton, Ontario, Canada, September 21, 2026 Sun Pharmaceutical Industries Limited (Sun Pharma) has announced the commercial...
BOSTON — September 22, 2026 Rhythm Pharmaceuticals announced that Health Canada has approved IMCIVREE® (setmelanotide) for weight management in...
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...
KIRKLAND, Québec, Canada, July 29, 2026 Pfizer Canada ULC announced that PREVNAR 20™, its 20-valent pneumococcal conjugate vaccine, has...
BURLINGTON, Mass., July 6, 2026 PharmaEssentia Corporation announced that its wholly owned Canadian subsidiary, FORUS Therapeutics Inc., has received...
NEW YORK, June 29, 2026 DarioHealth Corp. has announced a strategic collaboration with Beluga Health to create a provider-backed,...
NEW YORK & WESTFIELD, N.J., June 29, 2026 Talawar Therapeutics has announced a definitive business combination agreement with JATT...
KIRKLAND, Quebec, Canada & SHANGHAI, China, June 23, 2026 Organon Canada and Shanghai Henlius Biotech have expanded access to...
WINNIPEG, Manitoba – February 26, 2026 Emergent BioSolutions (NYSE: EBS) has announced approximately $140 million CAD in multiyear contract...
